glp 1 agonist weight loss mechanism GLP-1 Receptor Agonists as Treatments for Type 2 Diabetes Mechanisms of Action and Therapeutic
Description
These drugs, originally developed to manage diabetes, have gained significant attention for their weight loss benefits
Combining supplements is usually safe if total doses stay within recommended limits and additions are gradual, but check for overlapping ingredients and consult your provider especially with kidney disease or multiple medications
Incretin mimetics are a relatively new group of injectable drugs for treatment of type 2 diabetes and obesity
doi: 10.1097/MJT.0b013e3182204c16
